The Landscape of Laboratory Corruption
How widespread is corruption in the lab—and what can be done to combat it?
How widespread is corruption in the lab—and what can be done to combat it?
This webinar will explore the benefits of strategic, deliberate partnerships in order to improve access to quality diagnostic laboratory services, support more timely answers to advance patient care, and serve as a defense mechanism against acquisition
Though potential FDA LDTs regulation has drawn a lot of attention, other efforts could also have long-term effects on how labs do business.
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The FDA is adding International Organization for Standardization (ISO) guidelines to its “good manufacturing” requirements
The impending legislation that may determine Medicare lab fees from 2025 onward
This webinar highlights internal processes regarding diagnostics for Group A Streptococcus, and explains how these results benefit patients, providers, and staff
This webinar offers expert insight and advice on how adaptability helps lab staffers find suitable candidates for their organizations